ACSL3 and cancer: Among these, PEBP1/STK11 co-expression strongly negatively correlates in all cancer types with enzymes that increase the biosynthesis of fatty acids such as members of the ACSL family (ACSL1, ACSL3, ACSL4, ACSL5, and ACSL6).